Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?

Date publication

novembre 2021

Journal

Vaccine

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERCEANU Ana , Pr DECONINCK Eric

Tous les auteurs :
Pierron A, Bozon F, Berceanu A, Fontan J, Brion A, Deconinck E, Chirouze C, Brunel AS

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34740475

Résumé

Immunocompromised patients are at high-risk for severe influenza and invasive pneumococcal diseases (IPD). Despite the French Public Health Council (FPHC) and the 7th European Conference on Infections in Leukaemia (ECIL7) recommendations, vaccination coverage remains insufficient. This study aimed to estimate the coverage and determinants of influenza, pneumococcal and diphtheria-tetanus-poliomyelitis (dTP) vaccinations in hematological patients underlying chemotherapy.

Mots clés

Chemotherapy, General practitioners, Immunocompromised host, Influenza, Pneumococcal, Vaccination

Référence

Vaccine. 2021 Nov 2;: